Assignee
IMCYSE SA
BE·10 granted patents·23 pending applications·24 citations·filing 2013–2024
Top patents by PatentIndex Score
33 records- 0194US11407795B2Peptides and methods for the treatment of diabetesIMCYSE SA·Filed 2020·Granted Aug 9, 2022·4 cites·5 claims
- 0293US11760782B2Peptides and methods for the treatment of diabetesIMCYSE SA·Filed 2022·Granted Sep 19, 2023·2 cites·11 claims
- 0391US10808016B2Peptides and methods for the treatment of diabetesIMCYSE SA·Filed 2019·Granted Oct 20, 2020·6 cites·10 claims
- 0488US11226332B2Method for the detection, preparation and depletion of CD4+ t lymphocytesIMCYSE SA·Filed 2019·Granted Jan 18, 2022·3 cites·21 claims
- 0585US11718650B2Immunogenic peptides and their use in immune disordersIMCYSE SA·Filed 2020·Granted Aug 8, 2023·1 cites·8 claims
- 0684US12583891B2Peptides and methods for the treatment of diabetesIMCYSE SA·Filed 2023·Granted Mar 24, 2026·0 cites·11 claims
- 0783US11485768B2Immunogenic CD1d binding peptidesIMCYSE SA·Filed 2017·Granted Nov 1, 2022·3 cites·19 claims
- 0883US10729791B2Animal models for evaluating pharmaceutical compoundsIMCYSE SA·Filed 2016·Granted Aug 4, 2020·3 cites·18 claims
- 0983US2024207379A1Strategies to prevent and/or treat immune responses to soluble allofactorsIMCYSE SA·Filed 2024·Application pending·0 cites
- 1081US12023384B2Immunogenic peptides comprising an MHC class II T cell epitope and a redox motifIMCYSE SA·Filed 2020·Granted Jul 2, 2024·1 cites·10 claims
- 1181US2024034759A1Immunogenic peptides and their use in immune disordersIMCYSE SA·Filed 2023·Application pending·0 cites
- 1281US2024158464A1Immunogenic peptides and their use in transplantationIMCYSE SA·Filed 2023·Application pending·0 cites
- 1375US2024342297A1Novel immunogenic peptidesIMCYSE SA·Filed 2024·Application pending·0 cites
- 1472US11787849B2Methods and compounds for eliminating immune responses to therapeutic agentsIMCYSE SA·Filed 2016·Granted Oct 17, 2023·1 cites·12 claims
- 1571US2024109951A1Methods and compounds for eliminating immune responses to therapeutic agentsIMCYSE SA·Filed 2023·Application pending·0 cites
- 1671US2022119778A1Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccinationIMCYSE SA·Filed 2021·Application pending·0 cites
- 1767US2023265156A1Immunogenic cd1d binding peptidesIMCYSE SA·Filed 2022·Application pending·0 cites
- 1866US2024228558A9Peptides and methods for the treatment of neuromyelitis opticaIMCYSE SA·Filed 2023·Application pending·0 cites
- 1965US2022288179A1Immunogenic peptides with new oxidoreductase motifsIMCYSE SA·Filed 2019·Application pending·0 cites
- 2063US2025277223A1Methods of treating or preventing autoimmune diseasesIMCYSE SA·Filed 2022·Application pending·0 cites
- 2160US2024285737A1Improved methods of treatment using immunogenic peptidesIMCYSE SA·Filed 2022·Application pending·0 cites
- 2256US2023181638A1Immunogenic peptides with new oxidoreductase motifsIMCYSE SA·Filed 2021·Application pending·0 cites
- 2355US2023113747A1Immunogenic peptides with an oxidoreductase motif comprising a modified cysteineIMCYSE SA·Filed 2020·Application pending·0 cites
- 2455US2024189404A1Immunogenic peptides with extended oxidoreductase motifsIMCYSE SA·Filed 2021·Application pending·0 cites
- 2554US2021401976A1Immunogenic peptides with improved oxidoreductase motifsIMCYSE SA·Filed 2018·Application pending·0 cites
- 2653US2016108103A1Immunogenic peptides and their use in transplantationIMCYSE SA·Filed 2015·Application pending·0 cites
- 2753US2016091492A1Method for the detection, preparation and depletion of cd4+ t lymphocytesIMCYSE SA·Filed 2014·Application pending·0 cites
- 2853US2023340061A1Peptides and methods for the treatment of multiple sclerosisIMCYSE SA·Filed 2021·Application pending·0 cites
- 2951US2018228912A1Novel immunogenic peptidesIMCYSE SA·Filed 2015·Application pending·0 cites
- 3050US2023172894A1Combination treatment for fumarate-related diseasesIMCYSE SA·Filed 2021·Application pending·0 cites
- 3146US2023136112A1Methods for stratifying diabetes patientsIMCYSE SA·Filed 2020·Application pending·0 cites
- 3243US2016250255A1Methods for induction of antigen-specific regulatory t cellsIMCYSE SA·Filed 2014·Application pending·0 cites
- 3343US2015125880A1Methods for induction of antigen-specific regulatory t cellsIMCYSE SA·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →